EndoChoice® to Present at William Blair & Company's 36th Annual Growth Stock Conference
ALPHARETTA, Ga., June 1, 2016 /PRNewswire/ -- EndoChoice Holdings, Inc. (NYSE: GI) announced today that Mark Gilreath, Founder and Chief Executive Officer, and David Gill, President & Chief Financial Officer are scheduled to present at William Blair & Company's 36th annual Growth Stock Conference.
| Event: |
William Blair & Company 36th Annual Growth Stock Conference |
| Format: |
Presentation and One-on-One Meetings |
| Date: |
Tuesday, June 14, 2016 |
| Time: |
3:30 p.m. CT |
| Location: |
Chicago, IL |
Audio webcasts of the Company's presentation will be available by visiting the investor relations section of EndoChoice's website at www.endochoice.com. Replays of the presentation will be available for 90 days.
About EndoChoice:
Based near Atlanta, Georgia, EndoChoice® (NYSE: GI) is a medtech company focused on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices and infection control products and pathology services for specialists treating a wide range of gastrointestinal conditions, including colon cancer. EndoChoice leverages its direct sales organization to serve more than 2,500 customers in the United States and works with distribution partners in 30 countries. The Company was founded in 2008 and has rapidly developed a broad and innovative product portfolio, which includes the Full Spectrum Endoscopy® (Fuse®) system. EndoChoice, Fuse, and Full Spectrum Endoscopy are registered trademarks of EndoChoice, Inc.
Company Contact:
David Gill, President & Chief Financial Officer
678-585-1040
[email protected]
Investor Contacts:
Nick Laudico or Zack Kubow
The Ruth Group
646-536-7030 / 7020
[email protected]
[email protected]
SOURCE EndoChoice
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article